Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047865 · ClinicalTrials.gov registry record
Type 1 Diabetes Recurrence in Pancreas Transplants
A clinical trial of Diabetes Mellitus, Type 1, sponsored by University of Miami.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01047865 is a study of Diabetes Mellitus, Type 1 that is actively recruiting participants, run by University of Miami. The registered enrollment target is 400 participants, below the 1,263-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01047865, a study of Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis is that humoral and cellular islet-specific responses are an early risk factor for recurrence of autoimmunity and hyperglycemia in simultaneous pancreas-kidney (SPK) recipients independent of alloimmunity. This study will test the hypothesis and will assess their individual and combined predictive value.
Conditions Studied
Study Locations (1)
Florida
- University of Miami Miller School of Medicine Transplant Clinic - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2005-05 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01047865
The ClinicalTrials.gov registry entry for NCT01047865 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,263-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (68% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 0 interventions.
NCT01047865 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01047865 about?
NCT01047865 is a clinical study titled "Type 1 Diabetes Recurrence in Pancreas Transplants". The hypothesis is that humoral and cellular islet-specific responses are an early risk factor for recurrence of autoimmunity and hyperglycemia in simultaneous pancreas-kidney (SPK) recipients independent of alloimmunity. This study will test the hypothesis and will assess their individual and combin...
What is the current status of trial NCT01047865?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2005-05. Estimated completion is 2026-05.
What conditions does trial NCT01047865 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
Who is sponsoring clinical trial NCT01047865?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01047865 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
RECRUITING · Phase 1
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Islet Transplantation in Type 1 Diabetic Kidney Allograft
RECRUITING · Phase 2
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.